• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
KRTX

KRTX

Karuna Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD329.83

+0.09 (+0.03%)

Company Profile

CEO

William Meury

IPO Date

2019-06-28

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$329.75

Prev. Close

$329.74

Day Low

$329.75

Day High

$329.97

52W Low

$158.38

52W High

$329.99

Market Cap

$12.60B

Volume

1.28M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

27.3%

Avg Negative

2.5%

Avg Neutral

70.2%

News Feed

Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers

Business Wire·6/23/2021·↑ positive

Karuna Therapeutics Announces Pricing of Public Offering of Common Stock

Business Wire·3/1/2021·↑ positive

Karuna Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides General Business Update

Business Wire·2/25/2021·↑ positive

PureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia

Business Wire·2/25/2021·↑ positive

Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia

Business Wire·2/24/2021·↑ positive

Karuna Therapeutics to Participate at 10th Annual SVB Leerink Global Healthcare Conference

Business Wire·2/2/2021·↑ positive

Karuna Therapeutics Announces Appointment of Ronald Marcus, M.D., as Senior Vice President of Medical

Business Wire·1/26/2021·↑ positive

Karuna Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Business Wire·1/5/2021·↑ positive

Karuna Therapeutics Appoints Denice Torres, J.D., to its Board of Directors

Business Wire·12/22/2020·↑ positive

Karuna Therapeutics Appoints David Wheadon, M.D., to Its Board of Directors

Business Wire·12/3/2020·↓ negative